Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
about
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015
P2860
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Adjunctive rifampicin for Stap ...... ind, placebo-controlled trial.
@en
Adjunctive rifampicin for Stap ...... ind, placebo-controlled trial.
@nl
type
label
Adjunctive rifampicin for Stap ...... ind, placebo-controlled trial.
@en
Adjunctive rifampicin for Stap ...... ind, placebo-controlled trial.
@nl
prefLabel
Adjunctive rifampicin for Stap ...... ind, placebo-controlled trial.
@en
Adjunctive rifampicin for Stap ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P1433
P1476
Adjunctive rifampicin for Stap ...... ind, placebo-controlled trial.
@en
P2093
A Sarah Walker
Achyut Guleri
Alexander Szubert
Bernadette Young
Clive Graham
Cressida Auckland
Dakshika Jeyaratnam
David A Price
David Harvey
Deepa Nayar
P2860
P356
10.1016/S0140-6736(17)32456-X
P407
P577
2017-12-14T00:00:00Z